BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21994442)

  • 1. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease.
    Bertram S; Glowacka I; Müller MA; Lavender H; Gnirss K; Nehlmeier I; Niemeyer D; He Y; Simmons G; Drosten C; Soilleux EJ; Jahn O; Steffen I; Pöhlmann S
    J Virol; 2011 Dec; 85(24):13363-72. PubMed ID: 21994442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein.
    Heurich A; Hofmann-Winkler H; Gierer S; Liepold T; Jahn O; Pöhlmann S
    J Virol; 2014 Jan; 88(2):1293-307. PubMed ID: 24227843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.
    Glowacka I; Bertram S; Müller MA; Allen P; Soilleux E; Pfefferle S; Steffen I; Tsegaye TS; He Y; Gnirss K; Niemeyer D; Schneider H; Drosten C; Pöhlmann S
    J Virol; 2011 May; 85(9):4122-34. PubMed ID: 21325420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.
    Matsuyama S; Nagata N; Shirato K; Kawase M; Takeda M; Taguchi F
    J Virol; 2010 Dec; 84(24):12658-64. PubMed ID: 20926566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro.
    Kam YW; Okumura Y; Kido H; Ng LF; Bruzzone R; Altmeyer R
    PLoS One; 2009 Nov; 4(11):e7870. PubMed ID: 19924243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
    Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
    Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
    J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.
    Reinke LM; Spiegel M; Plegge T; Hartleib A; Nehlmeier I; Gierer S; Hoffmann M; Hofmann-Winkler H; Winkler M; Pöhlmann S
    PLoS One; 2017; 12(6):e0179177. PubMed ID: 28636671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry.
    Shulla A; Heald-Sargent T; Subramanya G; Zhao J; Perlman S; Gallagher T
    J Virol; 2011 Jan; 85(2):873-82. PubMed ID: 21068237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
    Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
    Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.
    Simmons G; Zmora P; Gierer S; Heurich A; Pöhlmann S
    Antiviral Res; 2013 Dec; 100(3):605-14. PubMed ID: 24121034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts.
    Bertram S; Heurich A; Lavender H; Gierer S; Danisch S; Perin P; Lucas JM; Nelson PS; Pöhlmann S; Soilleux EJ
    PLoS One; 2012; 7(4):e35876. PubMed ID: 22558251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
    Li K; Meyerholz DK; Bartlett JA; McCray PB
    mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein.
    Matveev EV; Ponomarev GV; Kazanov MD
    Microbiol Spectr; 2024 Feb; 12(2):e0353023. PubMed ID: 38189333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
    Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.
    Glowacka I; Bertram S; Herzog P; Pfefferle S; Steffen I; Muench MO; Simmons G; Hofmann H; Kuri T; Weber F; Eichler J; Drosten C; Pöhlmann S
    J Virol; 2010 Jan; 84(2):1198-205. PubMed ID: 19864379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
    Bertram S; Dijkman R; Habjan M; Heurich A; Gierer S; Glowacka I; Welsch K; Winkler M; Schneider H; Hofmann-Winkler H; Thiel V; Pöhlmann S
    J Virol; 2013 Jun; 87(11):6150-60. PubMed ID: 23536651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.
    Belouzard S; Chu VC; Whittaker GR
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5871-6. PubMed ID: 19321428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.
    Kuhn JH; Li W; Radoshitzky SR; Choe H; Farzan M
    Antivir Ther; 2007; 12(4 Pt B):639-50. PubMed ID: 17944271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization.
    Jia HP; Look DC; Hickey M; Shi L; Pewe L; Netland J; Farzan M; Wohlford-Lenane C; Perlman S; McCray PB
    Adv Exp Med Biol; 2006; 581():479-84. PubMed ID: 17037581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.